Viridian’s autoimmune eye disease shot passes Phase 3, but can it compete?news2026-03-30T15:28:50+00:00March 30th, 2026|Endpoints News|
Blackstone raises $6.3B life sciences fund in record fundraising haulnews2026-03-30T15:12:18+00:00March 30th, 2026|Endpoints News|
Takeda cuts 600+ US jobs; United’s stock rises on Tyvaso datanews2026-03-30T15:01:45+00:00March 30th, 2026|Endpoints News|
How the Iran War Has Rippled Across the Worldnews2026-03-30T14:51:02+00:00March 30th, 2026|The New York Times|
Why CPR Training Should Be Part of Every Family’s Health Plannews2026-03-30T14:41:47+00:00March 30th, 2026|Medical Device News Magazine|
#ACC26: Kardigan’s repeat dosing of blood pressure drug has no benefit over single shotnews2026-03-30T14:22:03+00:00March 30th, 2026|Endpoints News|
Eli Lilly to pay $115M upfront to Insilico in AI drug discovery dealnews2026-03-30T14:07:39+00:00March 30th, 2026|Endpoints News|
